Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Stomach Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Ventilator-Induced Lung Injury 1Skin Neoplasms 1Rectal Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Neoplasms, Squamous Cell 1Myelodysplastic Syndromes 1Liver Neoplasms 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Chronic 1Cytopenia 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Tretinoin 11Arsenic Trioxide 7Idarubicin 4Mitoxantrone 3Etoposide 3Daunorubicin 3Cytarabine 3Thioguanine 2Radiotherapy 2Cyclophosphamide 2sargramostim 1Watchful Waiting 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Mercaptopurine 1Hydroxyurea 1Filgrastim 1Busulfan 1Bortezomib 1Ascorbic Acid 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Promyelocytic, Acute × Ascorbic Acid × Clear all
NCT03624270 2022-10-04

Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia

The University of Hong Kong

Phase 2 Unknown
60 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡